A study in Diabetes Care showed type 2 diabetes patients treated with insulin who were noncompliant with clinic visits and medications were more likely to have higher glycated hemoglobin and face an increased risk of all-cause mortality.
Higher mortality risk seen in noncompliant diabetes patients
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|